关注
Ayşen Işık
Ayşen Işık
Selçuk Üniversitesi Biyokimya Bölümü Dr. Öğr. Üyesi
在 selcuk.edu.tr 的电子邮件经过验证
标题
引用次数
引用次数
年份
Design, synthesis, molecular modeling, DFT, ADME and biological evaluation studies of some new 1, 3, 4-oxadiazole linked benzimidazoles as anticancer agents and aromatase …
U Acar Çevik, I Celik, A Işık, I Ahmad, H Patel, Y Özkay, ZA Kaplancıklı
Journal of Biomolecular Structure and Dynamics, 1-15, 2023
592023
Synthesis, molecular modeling, quantum mechanical calculations and ADME estimation studies of benzimidazole-oxadiazole derivatives as potent antifungal agents
UA Çevik, I Celik, A Işık, RR Pillai, TE Tallei, R Yadav, Y Özkay, ...
Journal of Molecular Structure 1252, 132095, 2022
282022
Benzimidazole-hydrazone derivatives: Synthesis, in vitro anticancer, antimicrobial, antioxidant activities, in silico DFT and ADMET studies. Journal of molecular structure.
A Işık, U Acar Çevik, İ Çelik, HE Bostancı, A Karayel, G Gündoğdu, U İnce, ...
Journal of molecular structure, 2022
162022
Study on thiazolyl-hydrazone derivatives as acetylcholinesterase inhibitors
Y Özkay, L Yurttaş, U Abu Mohsen, B Sever, W Hussein, O Ozturk, ...
Clinical and Experimental Health Sciences 4 (1), 2014
16*2014
Synthesis, characterization, and molecular docking study of some novel imidazole derivatives as potential antifungal agents
A Işık, U Acar Çevik, BN Sağlık, Y Özkay
Journal of Heterocyclic Chemistry 56 (1), 142-152, 2019
142019
Design, synthesis and molecular docking studies of novel benzimidazole-1, 3, 4-oxadiazole hybrids for their carbonic anhydrase inhibitory and antioxidant effects
K Küçükoğlu, U Acar Çevik, H Nadaroglu, I Celik, A Işık, HE Bostancı, ...
Medicinal Chemistry Research 31 (10), 1771-1782, 2022
112022
Calixarenes: recent progress in supramolecular chemistry for application in cancer therapy
A Isik, M Oguz, A Kocak, M Yilmaz
Journal of Inclusion Phenomena and Macrocyclic Chemistry 102 (5), 439-449, 2022
112022
Synthesis, characterization, molecular docking, dynamics simulations, and in silico absorption, distribution, metabolism, and excretion (ADME) studies of new thiazolylhydrazone …
A Işık, U Acar Çevik, İ Çelik, T Erçetin, A Koçak, Y Özkay, Kaplancıklı, ...
Zeitschrift für Naturforschung C, 2022
102022
Synthesis, Molecular Docking, Dynamics, Quantum-Chemical Computation, and Antimicrobial Activity Studies of Some New Benzimidazole–Thiadiazole Hybrids
I Celik, UA Çevik, A Karayel, A Işık, U Kayış, UD Gül, HE Bostancı, ...
ACS omega 7 (50), 47015-47030, 2022
92022
Synthesis and molecular modelling of thiadizole based hydrazone derivatives as acetylcholinesterase and butyrylcholinesterase inhibitory activities
A Işık, U Acar Çevik, A Karayel, I Celik, T Erçetin, A Koçak, Y Özkay, ...
SAR and QSAR in Environmental Research 33 (3), 193-214, 2022
82022
Synthesis of new benzimidazole derivatives containing 1, 3, 4-thiadiazole: their in vitro antimicrobial, in silico molecular docking and molecular dynamic simulations studies
U Acar Çevik, A Işık, AE Evren, Ö Kapusız, ÜD Gül, Y Özkay, ...
SAR and QSAR in Environmental Research 33 (11), 899-914, 2022
62022
Synthesis, and docking studies of novel tetrazole-S-alkyl derivatives as antimicrobial agents
U Acar Çevik, İ Çelik, A Işık, ÜD Gül, G Bayazıt, HE Bostancı, Y Özkay, ...
Phosphorus, Sulfur and Silicon and the Related Elements, 2023
32023
Design, synthesis and biological evaluation of novel ketone derivatives containing benzimidazole and 1, 3, 4-triazole as CA inhibitors
UA Çevik, A Işık, R Kapavarapu, K Küçükoğlu, H Nadaroglu, HE Bostancı, ...
Journal of Molecular Structure 1295, 136770, 2024
22024
Design, synthesis, and molecular docking studies of benzimidazole‐1, 3, 4‐triazole hybrids as carbonic anhydrase I and II inhibitors
İ Çelik, U Acar Çevik, K Küçükoğlu, H Nadaroglu, HE Bostancı, A Işık, ...
Chemical Biology & Drug Design 103 (1), e14351, 2024
12024
Synthesis of Novel Thiazolyl-Hydrazine Derivatives and Activity Studies of Acetylcholinesterase (AChE) and Butyrylcholinesterase (BuChE)
A Işık, U Çevik Acar, T Erçetin, A Koçak
Bilecik Şeyh Edebali Üniversitesi Fen Bilimleri Dergisi 9 (1), 277-285, 2022
1*2022
Benzimidazole‐Containing Compounds as Anticancer Agents
U Acar Çevik, A Işik, B Kaya, R Kapavarapu, M Rudrapal, G Halimi, ...
ChemistrySelect 9 (32), e202401566, 2024
2024
Synthesis, DFT Calculations, In Silico Studies, and Antimicrobial Evaluation of Benzimidazole-Thiadiazole Derivatives
A Işık, U Acar Çevik, A Karayel, I Ahmad, H Patel, İ Çelik, UD Gül, ...
ACS omega 9 (16), 18469-18479, 2024
2024
Synthesis and Molecular Docking of New N-Acyl Hydrazones-Benzimidazole as hCA I and II Inhibitors
K Küçükoğlu, UA Çevik, H Nadaroglu, I Celik, A Işık, HE Bostancı, ...
Medicinal Chemistry (Shariqah (United Arab Emirates) 19 (5), 485, 2023
2023
Yeni tiyazol-hidrazinil türevlerinin sentezi, karakterizasyonu, moleküler doking ve kolinesteraz inhibisyon çalışmaları
UA ÇEVİK, I Ayşen, İ ÇELİK, T ERCETİN
Balıkesir Üniversitesi Fen Bilimleri Enstitüsü Dergisi 25 (2), 516-525, 2023
2023
Natural Sciences
A Ceylan, GŞ Karatoprak, Z Kocakaya, M Kocakaya, Ç Yıldız, Z Özsoy, ...
Evaluation 43 (4), 2022
2022
系统目前无法执行此操作,请稍后再试。
文章 1–20